A Phase IV Clinical Trial of Patients with Solid Tumors Receiving Lenograstim as Primary Prophylaxis for Chemotherapy-Induced Neutropenia, in a Docetaxel-Based Regimen

Table 6

Causes of death in 13 patients.

Cause	Number of patients
Disease progression	5
Embolism*	1
Intracranial hemorrhage*	1
Multiple organ failure	1
Pleural infusion	1
Septic shock	1
Airway obstruction	1
Pneumonia	1
Unknown	1

∗Within 30 days after last lenograstim administration.